marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-12-2024
Sangamo Therapeutics General and Administrative Expenses 2011-2024 | SGMO
Annual General and Administrative Expenses Sangamo Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 61.2 M | 62.7 M | 63.2 M | 67.1 M | 61.7 M | 46.7 M | 27.2 M | 26.3 M | 19.2 M | 15.7 M | 13.8 M | 12.1 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 67.1 M | 12.1 M | 39.7 M |
Quarterly General and Administrative Expenses Sangamo Therapeutics
| 2024-Q3 | 2024-Q2 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 11 M | 12 M | 13.9 M | 16 M | 18.1 M | - | 16.2 M | 15.1 M | 14.9 M | - | 14.5 M | 16.5 M | 16.1 M | - | 16.2 M | 17.9 M | 16.1 M | - | 14.9 M | 14.6 M | 17.1 M | - | 11 M | 11.3 M | 10.1 M | - | 6.42 M | 6.04 M | 7.28 M | - | 5.02 M | 11.1 M | 5.36 M | - | 4.56 M | 5.02 M | 4.73 M | - | 3.73 M | 3.97 M | 3.64 M | - | 3.16 M | 3.12 M | 3.31 M | - | 3.14 M | 2.74 M | 3.24 M | - | 3.59 M | 3.68 M | 3.54 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 18.1 M | 2.74 M | 9.52 M |